Sales of products for the production animal category in emerging markets were up significantly for French drugmaker Virbac in the first half. It was helped in South America by the integration of ...

Virbac consolidated revenue in the fourth quarter reached 225.7 M€, a significant +9.2% growth compared to the same period of last year and a +8.6% increase at constant scope. Growth was driven ...

FORT WORTH, Texas, Nov. 13 /PRNewswire/ -- Virbac Animal Health (Virbac) (OTC Pink Sheets: VBAC) announced today the planned launch of IVERHART MAX(TM) (ivermectin/pyrantel pamoate/praziquantel) in ...

Virbac Corp. (Nasdaq: VBAC), which makes animal health care products, said Monday the Food and Drug Administration has approved Iverhart, the company's canine-heartworm prevention drug. Virbac plans ...